CSL Shares Fall as Chairman Comments on Government Efforts to Avoid US Tariffs on Pharmaceuticals
MT Newswires Live
Jul 10
Shares of CSL (ASX:CSL) fell almost 2% in recent trading on Thursday after Chairman Brian McNamee commented on the Australian government's efforts to avoid US tariffs on pharmaceuticals.
McNamee said that he doesn't think US President Donald Trump's demands are "unreasonable," and urged the government to make Australia's Pharmaceutical Benefits Scheme more efficient, The Australian reported Wednesday.
Australia could speed up the system for approvals and the mechanism for pricing of innovative new drugs, but this would "come at a cost," and the country would "need to make a contribution," he said.
Trump warned that the US could impose up to a 200% tariff on pharmaceuticals after a grace period of a year to 18 months.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.